FDA To Remove Warnings From Hormone Replacement Therapy Products
SILVER SPRING, Md. — The U.S. Food and Drug Administration will begin to remove the “black box” warnings on hormone replacement therapy (HRT) products after recent studies showed that previous reports...To view the full article, register now.
Already a subscriber? Click here to view full article